BrokerLens

Senores Pharmaceuticals Limited IPO (SENORES)

Status
Listed
Security type
Mainboard
Price band
Rs.372 to Rs.391
Final issue price
Rs 391
Issue size
Not disclosed
Bidding opens
20 December 2024
Bidding closes
24 December 2024
Listing date
30 December 2024

Facts are NSE's own public-issue disclosures, refreshed periodically. Not investment advice; BrokerLens does not publish grey market premium (GMP) or recommend any IPO.

Sponsored
Zerodha

Brokerage-free equity & mutual fund investments

Trade with Zerodha's Kite platform and tools.

  • Zero brokerage on equity delivery
  • ₹20 flat for intraday, F&O, currency and commodity*
  • Free direct mutual fund investing
Open account →
*T&C apply. Investment in securities market are subject to market risks; read all related documents carefully before investing. Full disclaimer at zerodha.com/pricing. Member ID NSE (13906), BSE (6498), MCX (46025).
Sponsored
5paisa

Flat ₹20 per order, every segment

Trade stocks, derivatives and more on 5paisa's platform.

  • ₹20 flat for delivery, intraday and F&O
  • Free account opening
  • Listed on NSE and BSE
Open account →
*T&C apply. Investment in securities market are subject to market risks; read all related documents carefully before investing. SEBI Registration: INZ000010231.

Frequently asked questions

What is the price band for the Senores Pharmaceuticals Limited IPO?

The Senores Pharmaceuticals Limited IPO price band is Rs.372 to Rs.391 per share.

When does the Senores Pharmaceuticals Limited IPO open and close?

Bidding opens 20 December 2024 and closes 24 December 2024.

Is the Senores Pharmaceuticals Limited IPO a mainboard or SME issue?

Senores Pharmaceuticals Limited is a mainboard IPO, listing on NSE's main board.

When did the Senores Pharmaceuticals Limited IPO list?

Senores Pharmaceuticals Limited listed on 30 December 2024.

Does this page show the grey market premium (GMP) for Senores Pharmaceuticals Limited?

No. GMP is an unregulated, off-exchange estimate BrokerLens does not publish - see methodology. This page shows only NSE's own disclosed facts and, once bidding opens, NSE's own published subscription figures.

Is investing in the Senores Pharmaceuticals Limited IPO recommended by BrokerLens?

No. BrokerLens does not recommend any IPO, stock or broker. This page states public facts only; it is not investment advice.